The limited efficacy of mTOR inhibitors in PCa may reflect compensatory EV-mediated crosstalk, suggesting that co-targeting RAB1A and PD-1/PD-L1 could overcome microenvironmental immunosuppression. The gene discussed is CD274; the disease is posterior cortical atrophy.